Wilson Wolf Manufacturing Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Wilson Wolf Manufacturing Corporation's estimated annual revenue is currently $3.6M per year.
- Wilson Wolf Manufacturing Corporation's estimated revenue per employee is $155,000
Employee Data
- Wilson Wolf Manufacturing Corporation has 23 Employees.
- Wilson Wolf Manufacturing Corporation grew their employee count by 5% last year.
Wilson Wolf Manufacturing Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO focused on solving cell and gene therapy manufacturing challenges | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Director Operations | Reveal Email/Phone |
4 | Director QA/RA | Reveal Email/Phone |
5 | Quality Manager | Reveal Email/Phone |
6 | Warehouse, Safety, and Inventory Manager | Reveal Email/Phone |
7 | Senior R&D Engineer | Reveal Email/Phone |
8 | Admin. in EOS/Finance/Facilities/HR/IT | Reveal Email/Phone |
9 | Special Projects Liaison | Reveal Email/Phone |
10 | Human Resources / Finance | Reveal Email/Phone |
Wilson Wolf Manufacturing Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Wilson Wolf Manufacturing Corporation?
Wilson Wolf Manufacturing Corporation designs, manufactures, & markets cell culture devices including gas permeable cell culture systems. Our main focus is on expanding the G-Rex® production platform to meet the needs of the T cell therapy field. By eliminating the need for active gas exchange, rocking or stirring, these robust devices yield a more consistent and cost effective cell product than conventional culture systems. The G-Rex technology consistently yields larger, maximum density cell populations that are achieved through shortened culture durations, with no technician interventions or media exchange required, and with reduced overall media usage. Devices range from research & development through large scale, closed systems designed to meet the needs of commercial applications. Contact us with any questions and to find out how our expertise in the adoptive cell therapy field can be utilized to help your organization develop commercially viable manufacturing processes.
keywords:N/AN/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 23 | -49% | N/A |
#2 | $3M | 24 | 4% | N/A |
#3 | N/A | 24 | -8% | N/A |
#4 | $5.5M | 24 | -17% | N/A |
#5 | $5.4M | 24 | -8% | N/A |